Absence of myotonic dystrophy protein kinase (DMPK) mRNA as a result of a triplet repeat expansion in myotonic dystrophy - PubMed (original) (raw)
Absence of myotonic dystrophy protein kinase (DMPK) mRNA as a result of a triplet repeat expansion in myotonic dystrophy
P Carango et al. Genomics. 1993 Nov.
Abstract
Myotonic dystrophy is an autosomally dominant inherited disease in which system-wide abnormalities are caused by a triplet repeat expansion within the 3' untranslated region of the myotonic dystrophy protein kinase (DMPK) gene. To determine the effect an expanded repeat region has on DMPK expression, we have separated the chromosome 19 homologues from a 36-year-old woman with myotonic dystrophy into different cell lines by way of somatic cell hybridization. Hybrid DM9101 contains the normal DMPK allele (13 repeats), whereas hybrid DM1115 harbors the mutant allele (approximately 133 repeats). Reverse transcription/polymerase chain reaction (RT/PCR) amplification of coding sequences from the DMPK gene has shown both reduced levels of primary DMPK transcripts and impaired processing of these transcripts in hybrid cell line DM1115. These findings suggest that the presence of a large number of repeats in the 3' untranslated region of the DMPK gene reduces both the synthesis and the processing of DMPK mRNA, resulting in undetectable levels of processed DMPK mRNA from the mutant allele.
Similar articles
- Effect of myotonic dystrophy trinucleotide repeat expansion on DMPK transcription and processing.
Krahe R, Ashizawa T, Abbruzzese C, Roeder E, Carango P, Giacanelli M, Funanage VL, Siciliano MJ. Krahe R, et al. Genomics. 1995 Jul 1;28(1):1-14. doi: 10.1006/geno.1995.1099. Genomics. 1995. PMID: 7590731 - Effect of triplet repeat expansion on chromatin structure and expression of DMPK and neighboring genes, SIX5 and DMWD, in myotonic dystrophy.
Frisch R, Singleton KR, Moses PA, Gonzalez IL, Carango P, Marks HG, Funanage VL. Frisch R, et al. Mol Genet Metab. 2001 Sep-Oct;74(1-2):281-91. doi: 10.1006/mgme.2001.3229. Mol Genet Metab. 2001. PMID: 11592825 - Decreased DMPK transcript levels in myotonic dystrophy 1 type IIA muscle fibers.
Eriksson M, Hedberg B, Carey N, Ansved T. Eriksson M, et al. Biochem Biophys Res Commun. 2001 Sep 7;286(5):1177-82. doi: 10.1006/bbrc.2001.5516. Biochem Biophys Res Commun. 2001. PMID: 11527424 - [Effect on gene expression of the expanded CTG repeat on 3'-untranslated region of myotonic dystrophy (DM) protein kinase].
Furuya H, Imai N, Shiokawa K, Kira J. Furuya H, et al. Nihon Rinsho. 1999 Apr;57(4):932-6. Nihon Rinsho. 1999. PMID: 10222793 Review. Japanese. - Myotonic dystrophy protein kinase (DMPK) and its role in the pathogenesis of myotonic dystrophy 1.
Kaliman P, Llagostera E. Kaliman P, et al. Cell Signal. 2008 Nov;20(11):1935-41. doi: 10.1016/j.cellsig.2008.05.005. Epub 2008 May 18. Cell Signal. 2008. PMID: 18583094 Review.
Cited by
- Antisense therapy in neurology.
Lee JJ, Yokota T. Lee JJ, et al. J Pers Med. 2013 Aug 2;3(3):144-76. doi: 10.3390/jpm3030144. J Pers Med. 2013. PMID: 25562650 Free PMC article. Review. - Lens epithelial changes and mutated gene expression in patients with myotonic dystrophy.
Abe T, Sato M, Kuboki J, Kano T, Tamai M. Abe T, et al. Br J Ophthalmol. 1999 Apr;83(4):452-7. doi: 10.1136/bjo.83.4.452. Br J Ophthalmol. 1999. PMID: 10434869 Free PMC article. - Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy.
Timchenko LT, Miller JW, Timchenko NA, DeVore DR, Datar KV, Lin L, Roberts R, Caskey CT, Swanson MS. Timchenko LT, et al. Nucleic Acids Res. 1996 Nov 15;24(22):4407-14. doi: 10.1093/nar/24.22.4407. Nucleic Acids Res. 1996. PMID: 8948631 Free PMC article. - Myotonic dystrophy: molecular windows on a complex etiology.
Korade-Mirnics Z, Babitzke P, Hoffman E. Korade-Mirnics Z, et al. Nucleic Acids Res. 1998 Mar 15;26(6):1363-8. doi: 10.1093/nar/26.6.1363. Nucleic Acids Res. 1998. PMID: 9490778 Free PMC article. Review. - RNA metabolism in myotonic dystrophy: patient muscle shows decreased insulin receptor RNA and protein consistent with abnormal insulin resistance.
Morrone A, Pegoraro E, Angelini C, Zammarchi E, Marconi G, Hoffman EP. Morrone A, et al. J Clin Invest. 1997 Apr 1;99(7):1691-8. doi: 10.1172/JCI119332. J Clin Invest. 1997. PMID: 9120013 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources